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a b s t r a c t
Ethnopharmacological relevance: Buruli ulcer (BU) is the third most common mycobacterial infection in
the world, after tuberculosis and leprosy and has recently been recognized as an important emerging
disease. This disease is common in West Africa where more than 99% of the burden is felt and where
most affected people live in remote areas with traditional medicine as primary or only option. Reports
indicate that the ethnopharmacological control approach of the disease in such settings has shown
promise. However, no or very few compilations of traditional knowledge in using medicinal plants to
treat BU have been attempted so far. This review aimed to record medicinal plants used traditionally
against BU in three countries in West Africa: Ivory Coast, Ghana and Benin and for which ethnopharma-
cological knowledge supported by pharmacological investigations has been reported. The information
recorded in this review will support further pharmacological research to develop appropriate drugs for a
better BU control.
Material and methods: A systematic review of the literature on ethnobotanical use and anti-BU activity of
plants reported for BU treatment was performed. The approach consisted to search several resources,
including Technical Reports, Books, Theses, Conference proceedings, web-based scientiﬁc databases such
as publications on PubMed, Science direct, Springer, ACS, Scielo, PROTA, Google and Google scholar
reporting ethnobotanical surveys and screening of natural products against Mycobacterium ulcerans. This
study was limited to papers and documents published either in English or French reporting ethnophar-
macological knowledge in BU treatment or pharmacological potency in vitro. This review covered the
available literature up to December 2014.
Results: The majority of reports originated from the three most affected West African countries (Cote
d’Ivoire, Ghana and Benin). Though, 98 plant species belonging to 48 families have been identiﬁed as
having anti-BU use, many have received no or little attention. Most of the pharmacological studies were
performed only on 54 species. To a lesser extent, ethnopharmacological knowledge was validated in vitro
for only 13 species. Of those, seven species including Ricinus comminus, Cyperus cyperoides (cited as
Mariscus alternifolius), Nicotiana tabacum, Mangifera indica, Solanum rugosum, Carica papaya, andMoringa
oleifera demonstrated efﬁcacy in hospitalised BU patients. Four isolated and characterized compounds
were reported to have moderate bioactivity in vitro against M. ulcerans.
Conclusions: This review compiles for the ﬁrst time ethnopharmacologically useful plants against BU. The
phamacological potential of 13 of them has been demonstrated in vitro and support BU evidence-based
traditional medicines. In addition, 7 species showed activity in BU patients and have emerged as a
promising source of the traditional medicine for treatment of BU. Yet, further safety and efﬁcacy study
should be initiated prior any approval as alternative therapy. Overall, a huge gap in knowledge appeared,
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suggesting further well-planned and detailed investigations of the in vitro, in vivo, and safety properties
of the claimed anti-BU plants. Therefore, plants with medicinal potential should be scrutinized for
biologically active compounds, using bioassay-guided fractionation approach to provide new insights to
ﬁnd novel therapeutics for BU control.
& 2015 Published by Elsevier Ireland Ltd.
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1. Introduction
Buruli ulcer (BU) is a necrotizing disease of the skin, subcuta-
neous tissue and bone and it is caused by the environmental
pathogen Mycobacterium ulcerans. This disease is the third most
common mycobacterial infection in the world, after tuberculosis
and leprosy (WHO, 2011). The pathogenesis of BU is associated
with mycolactone, a lipidic exotoxin produced by M. ulcerans that
has cytotoxic and immunosuppressive properties (Martins et al.,
2012). It is largely a problem of people living in remote rural areas.
How exactly M. ulcerans is transmitted to humans remains
unknown, but in contrast to tuberculosis or leprosy, the infection
is acquired directly or indirectly from the environment and not
through contact with other patients (Stinear and Johnson, 2008).
At least 33 subtropical and temperate countries have reported
cases of BU. Fifteen of these countries have reported 5000–6000
annual cases. In Asia and the Western Paciﬁc, most cases occur in
tropical and subtropical regions except in Australia, China and
Japan. In West Africa, Benin, Ivory Coast and Ghana reported most
of the cases of which almost half occurred in Ivory Coast (WHO,
2013). According to WHO, Africa bears 99% of the global burden of
this disease.
Early reports have suggested that wide surgical excision was
the only effective treatment (MacCallum et al., 1948) for BU and
also, early trials with clofazimine (Revill et al., 1973) in the
antibiotic era demonstrated only marginal beneﬁts. In 2005, the
WHO introduced new provisional antibiotic treatment guidelines
for BU following a successful pilot study from Ghana which
conﬁrmed that human lesions can be sterilised with antibiotics
(Etuaful et al., 2005). This was supported by encouraging reports of
success with the protocol in a series of cases from Benin (Chauty
et al., 2007). The WHO protocol has led to a new approach to
treatment with the potential to reduce cost, to allow delivery of
care closer to the homes of patients, and to encourage patients to
present earlier as the fear of requiring major surgery is lessened.
The combination treatment protocol involves oral intake of
Rifampicin, 10 mg/kg body weight daily for 8 weeks plus Strepto-
mycin, 15 mg/kg body weight by intramuscular injection daily for
8 weeks. Although recent experience indicates that combination
chemotherapy with Streptomycin and Rifampicin improves cure
rates, the utility of this regimen is limited by the 56 days duration
of treatment, potential toxicity and required parenteral adminis-
tration of streptomycin (Johnson, 2010; Zhang et al., 2013). In
addition drug–drug interactions caused by Rifampicin (Chauty
et al., 2007; Johnson, 2010; Zhang et al., 2013) and the indirect
cost to family due to the long stay associated with the economic
burden limit this protocol. On the other hand, surgery, which is
however necessary for some severe forms of the disease (large
ulcerated forms, disseminated forms, and osteomyelitis) to correct
deformities and improve wound healing (Kibadi et al., 2010) is
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neither affordable nor accessible to a large proportion of the
population (Johnson et al., 2004). Furthermore, although BU is a
treatable disease, its burden is increasingly felt due to inappropri-
ate control measures and poor emphasis in developing new anti-
BU drugs.
Because of cultural believes and/or budgetary constraints,
traditional plant-based treatments remain the ﬁrst option for
many populations in poor remote areas (Johnson et al., 2004).
For poor and sick persons, modern treatment is not only expen-
sive, but is also subject to side effects, mutilation and amputation
(Stienstra et al., 2002). Reports have indicated that plant products
selected based on traditional knowledge might be of great impor-
tance in the early treatment and prevention of BU at an affordable
cost. However, there remain huge gaps in knowledge about the
real efﬁcacy of potions, their standardization, and active principles.
The scope of this review is a survey of current knowledge on
medicinal plants used traditionally to treat BU and for which
ethnopharmacological reports supported by pharmacological data
have been documented. It is anticipated that information recorded
herein will support further detailed investigations opening on
improved tools for better control of BU and eventually other
mycobacterial infections.
The data presented here were obtained from web-based search
of publications on PubMed, Science direct, Springer, ACS, Scielo,
Google and Google scholar databases reporting ethnobotanical
uses and screening of natural products against BU using the
keywords “medicinal plantsþBuruli ulcer”, “ethnobotani-
calþBuruli ulcer”, “natural products”, “antimycobacterial screen-
ing”, “Buruli ulcer”, “M. ulcerans”, “mycobacteria”, and “Traditional
medicineþBuruli ulcer”. In addition, Technical Reports, Books,
Theses, and Conference proceedings were study. This literature
survey was limited to papers and documents published either in
English or French. All retrieved information from documents
reporting either ethnopharmacological knowledge in BU treat-
ment or pharmacological potency in vitro against M. ulcerans is
discussed here. This review covers the available literature up to
December 2014. All plant species have been validated taxonomi-
cally with www.theplantlist.org (accessed December 2014).
2. Ethnopharmacological use of plants to control BU
Globally, the proportion of the populations using traditional
remedies based on plants to treat BU varies widely. Mostly in the
rural African areas, the use of plant medicines plays an important
role in daily health care. These medicines are sometimes preferred
to modern medicines. Generally, specialized pharmacopoeia is
practiced by traditional healers, and the popular or general
pharmacopoeia is common knowledge in speciﬁc communities.
From data collected in the framework of this review, parts or
whole plants are prepared and administered per os and/or locally
as pomade and bandage. Most remedies are mixtures of parts of
two or more plant species and water is the main solvent.
Generally, traditional treatment for BU is done in four steps,
diagnosis, necrosis ablation, wound curing, and exorcism. Plants
are used in the second and third steps of treatment (Johnson et al.,
2004).
2.1. Overview of studies on plants used as treatment for Buruli ulcer
in traditional medicine
2.1.1. Ethnopharmacological studies
Ethnopharmacological investigations mainly involve in-depth
interviews guided by appropriately designed questionnaires con-
sisting of both closed and open-ended questions (Owusu-Sekyere,
2012; Trébissou et al., 2014; Seefeld et al., 2013), check list
interview (Sam et al., 2013; Yemoa et al., 2008; Addo et al.,
2007; Vangah et al., 2000), observation and focus group discus-
sions (Trébissou et al., 2014; Adjet et al., 2013), and subsequent
experimental investigation of indigenous medicines based on
determination of in vitro activity as an approach to drug discovery.
Indeed, the majority of studies reported in this paper were carried
out in Health centres speciﬁcally dedicated to the treatment of
Buruli ulcer; providing almost certainly a guarantee that they were
all affected by this pathology. The identity of plants is usually
authenticated by competent authorities such Botany department
or herbarium. Limitations to the interview approach might be the
reluctance of some herbal practitioners to disclose plants names
and combinations. Moreover, potions trials on BU patients was of
good quality as it provided direct evidence of efﬁcacy with a
complete pattern of the disease (Trébissou et al., 2014).
2.1.2. Extraction and isolation
Extraction methods generally mimic herbal practitioners’
approach to prepare decoctions or infusions using mainly water
and palm wine (Yemoa et al., 2015, 2011; Addo et al., 2007; Kone
et al., 2007, 2009). Other extraction procedures include the use of
ethanol or organic solvents of increasing polarity (hexane, dichlor-
omethane, ethyl acetate and water) to partition plant materials.
Isolation of active principles generally follows a bio-guided chro-
matographic fractionation approach (Yemoa et al., 2015). The
characterization of isolated compounds is performed using physi-
cal and spectroscopic techniques.
2.1.3. Antimicrobial assays
Antimicrobial activity testing assays are generally performed
using cultured M. ulcerans strains and isolates. Rifampicin is
usually incorporated as positive control (Yemoa et al., 2015).
Susceptibility assays are conducted using the proportion method
where inhibitors are incorporated into Löwenstein–Jensen media
at deﬁned concentrations (Addo et al., 2007; Coulibaly et al., 2011;
Kone et al., 2007), or the resazurin method on microtitre plate
format where mycobacteria are incubated with inhibitors in
supplemented Middlebrook 7H9-S broth (Yemoa et al., 2011,
2015). In all cases, activity is usually deﬁned as minimal inhibitory
concentration (MIC) considered as the lowest drug concentration
that inhibits the growth of at least 99% of mycobacteria in culture
relative to negative control.
2.1.4. Toxicity studies
Toxicity studies were not considered in all retrieve information,
but for the sake of providing holistic information on medicinal
plants used, data on toxicity of plants that showed activity either
in vitro or on BU patients are provided and they are often
conducted in rodent models.
The present review has identiﬁed plants that are reported to be
used to treat BU (Table 1). Some of these plants have undergone
various degrees of scientiﬁc investigation, including testing on
patients. In the following subsections, plants which have been
investigated so far as potential sources of therapy against BU are
presented.
2.1.5. Traditional medicine reports
2.1.5.1. Places and frequency of citation of plant species. The review
has identiﬁed 98 plant species belonging to 88 genera and 48 plant
families that are used for the treatment of BU or related
symptoms. Places and frequency of citation of species used to
treat BU are summarized in Table 1.
Most of the cited plants were from Benin, Ivory Coast, and
Ghana (Table 1, Fig. 1) where 79 species were individually reported
in only one country, including 35 in Ghana, 32 in Benin and 12 in
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Table 1
Plants used ethnobotanically against Buruli ulcer in three West African countries: Benin, Ghana, and Ivory Coast.
Family Species Part
used
Formulation and mode of usage Country Common /local
name
Frequency
of citation
References
Amaranthaceae Dysphania ambrosioides (L.)
Mosyakin & Clemants (cited
as Chenopodium ambrosioides
L.)
Leaves Decoction used for BU treatment Benin,
Ghana
Dangme be
(twi)
2 Yemoa et al. (2008,
2011), Seefeld et al.
(2013)
Amaryllidaceae Allium cepa L. Bulb Infusion used in BU treatment Benin Unspeciﬁed 1 Yemoa et al. (2008,
2011)
Anacardiaceae Lannea kerstingii (Engl.) K.
Krause
Leaves Decoction used in BU treatment Benin Unspeciﬁed 1 Yemoa et al. (2008,
2011)
Mangifera indica L. Leaves,
roots
Used as pomade or disinfectant Ivory
Coast
Mango bark 2 Adjet et al. (2013),
Trébissou et al.
(2014)
Infusion: The leaves and roots are heated
and applied to the wound twice a day
Spondias mombin L. Leaves Decoction and trituration used in BU
treatment
Benin;
Ivory
Coast
Troman
(baoulé)
1 Yemoa et al. (2008,
2011)
Annonaceae Cleistopholis patens (Benth.)
Engl. & Diels
Leaves Exudate from leaves is used for BU
treatment
Ghana Unspeciﬁed 1 Owusu-Sekyere
(2012)
Monodora myristica (Gaertn.)
Dunal
Seed Seed decoction is used for BU treatment Benin Unspeciﬁed 1 Yemoa et al. (2008,
2011)
Xylopia aethiopica (Dunal) A
Rich
Fruit,
seed
Pomade with seed for ulcer dressing. Benin;
Ivory
Coast
Sidian (baoulé) 1 Adjet et al. (2013),
Yemoa et al. (2008,
2011)
Decoction of fruit used for BU treatment.
Apocynaceae Alstonia boonei De Wild. Leaves Stem bark paste is used to bandage the
washed ulcer and changed every other day
Ghana Sonuro;
nyamedua
2 Sam et al. (2013),
Addo et al. (2007)
Holarrhena ﬂoribunda (G.
Don) T. Durand et Schinz
Root Decoction used for BU treatment Benin kpakpatoun 1 Yemoa et al. (2008,
2011, 2015)
Mondia whitei (Hook.f.)
Skeels
Root Mixed with local alcohol to produce a bitter
and spread over the ulcer
Ghana Asasehuam 1 Seefeld et al. (2013)
Pergularia daemia (Forssk.)
Chiov.
Leaves Leaves are boiled and spread over the ulcer Ghana Bankeke 1 Seefeld et al. (2013)
Periploca nigrescens Afzel.
(cited as Parquetina
nigrescens (Afzel.) Bullock)
Leaves Used as in BU treatment Ivory
Coast,
Benin
Sroboué
(baoulé)
2 Yemoa et al. (2008,
2011), Adjet et al.
(2013)
Used as pomade or disinfectant
Secamone afzelii (Roem. &
Schult.) K.Schum.
Areal
part
Herbs are cooked as an infusion to wash and
heal the ulcer
Ghana Korantema 1 Seefeld et al. (2013)
Strophanthus hispidus DC. Root Decoction or maceration of root is used to
wash the ulcer 3 times per day during 10
days or more according to the size of the
wound in the BU treatment.
Benin Unspeciﬁed 1 Yemoa et al. (2008,
2011)
Araceae Aglaonema commutatum
Schott
Leaves Infusion of leaves is used for BU treatment Ghana Unspeciﬁed 1 Addo et al. (2007)
Anchomanes difformis (Bl.)
Engl.
Rhizome Decoction used for BU treatment Benin Unspeciﬁed 1 Yemoa et al. (2008)
Arecaceae Borassus aethiopum Mart. Flower The ﬂower is pressed to the wound for BU
treatment
Ghana Fan palm 1 Owusu-Sekyere
(2012)
Elaeis guineensis Jacq. Leaves The leaf is squeezed and the juice obtained is
used as pomade or disinfectant in BU
treatment
Ivory
Coast
N’mé (baoulé), 1 Adjet et al. (2013)
Asparagaceae. Dracaena arborea (Willd.)
Link
Leaves Leaves are cooked as an infusion to wash
and heal the ulcer
Ghana Ntome (twi),
Anyatsi (Ewe)
1 Seefeld et al. (2013)
Bignoniaceae Newbouldia laevis (P. Beauv.)
Seem
Root Trituration used for BU treatment Benin Unspeciﬁed 1 Yemoa et al. (2008,
2011)
Spathodea campanulata P.
Beauv.
Leaves,
Root,
Stem
bark
Treatment of BU relief for skin conditions,
swollen cheeks, body rashes.
Ghana,
Ivory
Coast,
Benin
Biébiésrili
(baoulé),
Kwakuo ninsuo
(twi)
4 Adjet et al. (2013),
Sam et al. (2013),
Addo et al. (2007),
Yemoa et al. (2008,
2011)
Disinfectants: Leaves and stem bark are
used for sore and ulcer dressing. Paste of
bark used to bandage ulcer. Root/bark
infusion is used for BU treatment.
Cotton wool is soaked in decoction of leaf
or fresh stem bark to clean sore, paste of
bark used to bandage ulcer
Stereospermum kunthianum
Cham
Root Root decoction used for BU treatment Benin Unspeciﬁed 1 Yemoa et al. (2008,
2011)
Capparaceae Euadenia eminens Hook.f. root Grinded roots are directly applied on the
ulcer
Ghana Dinsinkro 1 Seefeld et al. (2013)
Ritchiea capparoides
(Andrews) Britten
Root Root maceration is used for BU treatment Benin Unspeciﬁed 1 Yemoa et al. (2008,
2011)
Caricaceae Carica papaya L. Root,
Leaves
Infusion: leaves and roots of papaya (Carica
papaya) are heated and applied to the
wound twice a day.
Ivory
Coast
Papayas Oﬂê or
loﬂê (baoulé)
2 Adjet et al. (2013),
Trébissou et al.
(2014)
Pomade: fresh root is mixed with Xylopia
aethiopica seed to form a past used for
ulcer bandage
Cleomaceae Cleome gynandra L. Whole
plant
Grinded herbs are directly applied on the
ulcer
Ghana Sogbi 1 Seefeld et al. (2013)
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Table 1 (continued )
Family Species Part
used
Formulation and mode of usage Country Common /local
name
Frequency
of citation
References
Clusiaceae Garcinia kola Heckel Root Root pulverisation or infusion used for BU
treatment
Benin Unspeciﬁed 1 Yemoa et al. (2008,
2011)
Combretaceae Anogeissus leiocarpa (DC.)
Guill. & Perr. (cited as
Anogeissus leiocarpus (DC.)
Guill. & Perr)
Leaves,
root
Decoction: powder from dried and crushed
barks for deep ulcer
Benin Unspeciﬁed 1 Yemoa et al. (2008,
2011)
Terminalia glaucescens
Planch. ex Benth.
Bark/
root
Decoction is used for BU treatment Benin Unspeciﬁed 1 Yemoa et al. (2008,
2011)
Compositae Chromolaena odorata (L.) R.M.
King & H.Rob.
Leaves Leaf is washed in hot water and made into
paste and used to bandage ulcer.
Ghana,
Ivory
Coast
Acheampong,
Indépendance
(baoulé)
2 Sam et al. (2013),
Adjet et al. (2013)
Used as pomade or disinfectant in BU
treatment
Launaea taraxacifolia (Willd.)
Amin ex C.Jeffrey
Leaves Decoction used for BU treatment Benin Unspeciﬁed 1 Yemoa et al. (2008,
2011)
Vernonia amygdalina Delile Leaves Used as for BU treatment Benin,
Ghana
Gboti 2 Yemoa et al. (2008,
2011), Seefeld et al.
(2013)
Crassulaceae Bryophyllum pinnatum (Lam.)
Oken
Leaves Leaves are used for BU treatment Benin Unspeciﬁed 1 Yemoa et al. (2008,
2011)
Cucurbitaceae Kedrostis foedissima (Jacq.)
Cogn.
Leaves Trituration of leave is used for BU treatment Benin Unspeciﬁed 1 Yemoa et al. (2008,
2011)
Cyperaceae Cyperus cyperoides (L.)
Kuntze. (cited as Mariscus
alternifolius Vahl.)
Leaves Maceration: Leaves are pressed in the palms
and the substance obtained was applied to
the wound twice a day
Ivory
Coast
Idjré 1 Trébissou et al.
(2014)
Euphorbiaceae Alchornea cordifolia
(Schumach. & Thonn.) Müll.
Arg.
Leaves Leave paste used to bandage ulcer Ghana Agyama 1 Sam et al. (2013)
Euphorbia kamerunica Pax. Stem
bark
Decoction is used as BU treatment Benin Unspeciﬁed 1 Yemoa et al. (2008,
2011)
Euphorbia unispina N.E.Br. Trunk Decoction are used as BU treatment Benin Unspeciﬁed 1 Yemoa et al. (2008,
2011)
Jatropha curcas L. Leaves Leaves are used as pomade or disinfectant. Ghana,
Benin,
Ivory
Coast
Aplôplô
(baoulé)
3 Addo et al. (2007),
Adjet et al. (2013),
Yemoa et al. (2008,
2011)
Decoction of leaves is used as BU
treatment.
Tonic 3: Leaves mixed with Gossypium
hirsutum L., Physalis angulate L., Delonix
regia (Hook.) Raf. is used for treatment of
BU symptoms.
Jatropha gossypifolia L. Leaves Pulverised leaves are used as BU treatment Benin Unspeciﬁed 1 Yemoa et al. (2008,
2011)
Manihot esculenta Crantz
(cited as Manihot utilisima
Pohl)
Leaves Paste of leaf or tuber used to bandage ulcer
after washing ulcer with infusion of Vernonia
amygdalina leave
Ghana Bankye 1 Sam et al. (2013)
Ricinus communis L. Leaves The leaves are pressed in the palms and the
substance obtained is applied to the wound
twice a day (maceration).
Ivory
Coast
Attédé 1 Trébissou et al.
(2014)
Humiriaceae Sacoglottis gabonensis (Baill.)
Urb.
Stem
bark
Stem bark decoction is taken orally to treat
or disinfect the ulcer.
Ivory
Coast
Unspeciﬁed 1 Kone et al. (2007)
Alternatively the ulcer is recovered with
ﬁne powder as bandage.
Lamiaceae Ocimum americanum L. (cited
as Ocimum canum Sims)
Leaves Infusion used for BU treatment Ghana,
Benin
Ahame 2 Seefeld et al. (2013),
Yemoa et al. (2008,
2011)
Ocimum gratissimum L. (cited
as Ocimum viride Willd.)
Leaves Infusion used for BU treatment Ghana,
Benin
Onunumu
(Twi)
2 Seefeld et al. (2013),
Yemoa et al. (2008,
2011)
Hoslundia opposita Vahl Leaves The juice of the fresh leaves is applied to
wounds
Ghana Abrewaninsu 1 Seefeld et al. (2013)
Leguminosae Albizia zygia (DC.) J.F.Macbr. Seed Roasted seed paste used to bandage the
ulcer for treatment after washing ulcer with
infusion of Momordica charantia L. leaf
Ghana Nkroma 1 Sam et al. (2013)
Bauhinia thonningii Schum
(cited as Piliostigma
thonningii (Schum.) Milne-
Redh.)
Leaves Decoction used in BU treatment. Benin,
Ivory
Coast
Djamla
(baoulé)
2 Adjet et al. (2013),
Yemoa et al. (2008,
2011)
Leaves are also used as pomade or
disinfectant
Erythrophleum suaveolens
(Guill. et Perr.) Brenan
Root or
stem
bark
Decoction or pulverisation of root or stem
bark is used to wash the ulcer and powder
apply 3 times per day during 3 to 4 days or
more according to the size of the wound. In
addition the decoction is administered as
tea. The treatment can last from 2 weeks to
many months in the BU treatment.
Benin Unspeciﬁed 1 Yemoa et al. (2008,
2011)
Philenoptera cyanescens
(Schum. & Thonn.) Roberty
(cited as Lonchocarpus
Root Maceration of root is used for BU treatment Benin Unspeciﬁed 1 Yemoa et al. (2008,
2011)
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Table 1 (continued )
Family Species Part
used
Formulation and mode of usage Country Common /local
name
Frequency
of citation
References
cyanescens (Schum. et
Thonn.) Benth)
Senna alata (L.) Roxb. (cited
as Cassia alata L.)
Leaves Leave paste used to bandage ulcer for
therapy; treatment of Skin diseases
Ghana Yemnnua/
Sempe
2 Sam et al. (2013),
Addo et al. (2007)
Tetrapleura tetraptera
(Schum. et Thonn.) Taub
Fruit Maceration used for BU treatment Ghana,
Benin
Prekese 2 Yemoa et al. (2008,
2011), Seefeld et al.
(2013)
Loganiaceae Spigelia anthelmia L. Leaves Infusion of leaves mixed with grains Zea
mays (Tonic 1) is used for BU Treatment
Ghana Unspeciﬁed 1 Addo et al. (2007)
Loranthaceae Tapinanthus bangwensis
(Engl. & K. Krause) Danser
Leaves Ground leaves are directly applied on the
ulcer
Ghana Logblote 1 Seefeld et al. (2013)
Malvaceae Cola nitida (Vent.) Schott &
Endl.
Fruit Used as pomade or disinfectant Ivory
Coast
Wêssê (baoulé) 1 Adjet et al. (2013)
Sida acuta Burm.f. Leaves Ground leaves were directly applied on the
ulcer
Ghana Unspeciﬁed 1 Seefeld et al. (2013)
Melastomataceae Heterotis rotundifolia (Sm.)
Jacq.-Fél. (cited as Dissotis
rotundifolia (Sm.) Triana)
Leaves Decoction used in BU treatment Benin Unspeciﬁed 1 Yemoa et al. (2008,
2011)
Meliaceae Azadirachta indica A.Juss. Leaves Leaf is ground into a paste and taken orally
for BU treatment
Ghana Neem Tree 1 Owusu-Sekyere
(2012)
Khaya senegalensis (Desv.) A.
Juss.
Stem
bark
mixed with local alcohol to produce a bitter
administered orally
Ghana Mahogany 1 Seefeld et al. (2013)
Turraea heterophylla Sm. Leaves Leaves are mixed with local alcohol to
produce a bitter administered orally
Ghana Ahunanyankwa 1 Seefeld et al. (2013)
Moraceae Ficus asperifolia Miq. Bark Used for BU treatment Ghana Sand paper
tree/
Onyannkyeren
1 Owusu-Sekyere
(2012)
Ficus exasperata Vahl Leaves Leaf paste used to bandage ulcer. Ghana,
Benin
Nyankyerene 2 Sam et al. (2013),
Yemoa et al. (2008,
2011)
Used as in BU treatment
Moringaceae Moringa oleifera Lam. Leaves The aqueous plant extract is administered by
adding it into diet for six weeks treatment of
BU.
Ghana,
Ivory
Coast
Unspeciﬁed 2 Kodia et al. (2014),
Addo et al. (2007)
Musaceae Musa acuminata Colla (cited
as Musa sinensis Sagot ex
Baker)
Stem Maceration is used for BU treatment Benin Unspeciﬁed 1 Yemoa et al. (2008,
2011)
Musa paradisiaca L. Stem Pomade is made with Stem and kaolin is
used for ulcer bandage
Ivory
Coast
Manda
(baoulé)
1 Adjet et al. (2013)
Myrtaceae Syzygium aromaticum (L.)
Merr. & L.M.Perry (cited as
Eugenia aromatica (L.) Baill.)
Seed Decoction used in BU treatment Benin Unspeciﬁed 2 Yemoa et al. (2008,
2011), Addo et al.
(2007)
Nyctaginaceae Boerhavia diffusa L. Whole
plant
Ground herbs are directly applied on the
ulcer
Ghana Unspeciﬁed 1 Seefeld et al. (2013)
Boerhavia erecta L. Leaves
and root
Decoction used in BU treatment Benin Unspeciﬁed 1 Yemoa et al. (2008,
2011)
Phyllanthaceae Bridellia ferruginea Benth. Stem
bark
Trituration is used as BU treatment Benin Unspeciﬁed 1 Addo et al. (2007),
Yemoa et al. (2008,
2011)
Hymenocardia acida Tul. Bark Decoction is used as BU treatment Benin Unspeciﬁed 1 Yemoa et al. (2008,
2011)
Phyllanthus amarus
Schumach. & Thonn.
Leaves Used for BU treatment Ivory
Coast
Unspeciﬁed 1 Coulibaly et al.
(2011)
Phyllanthus muellerianus
(Kuntze) Exell
Leaves Leaves are boiled and spread over the ulcer Ghana Brontwi or
awobe
1 Seefeld et al. (2013)
Plantaginaceae Gratiola ofﬁcinalis L. Bark Decoction of bark is used in BU treatment Ghana Unspeciﬁed 1 Addo et al. (2007)
Piperaceae Piper guineense Schum. &
Thonn.
Seed Infusion used for BU treatment Benin Unspeciﬁed 1 Yemoa et al. (2008,
2011)
Poaceae Eleusine indica (L.) Gaertn. Whole
plant
Pulverization used for BU treatment Benin Unspeciﬁed 1 Yemoa et al. (2008,
2011)
Imperata cylindrica (L.)
Raeusch.
Root Used as pomade or disinfectant Ivory
Coast
Awahi (baoulé) 1 Adjet et al. (2013)
Zea mays L. Grains Infusion of Zea mays grains mixed with
Spigelia anthelmia leaves for BU Treatment
(tonic 1)
Ghana Unspeciﬁed 1 Addo et al. (2007)
Polygalaceae Carpolobia lutea G. Don. Stem Pulverisation of stem is used in BU
treatment
Benin Unspeciﬁed 1 Yemoa et al. (2008,
2011)
Portulacaceae Portulaca oleraccea L. Leaves Leaves are mixed with local alcohol and
taken orally
Ghana Adwere 1 Seefeld et al. (2013)
Rubiaceae Gardenia ternifolia Schumach.
& Thonn.
Bark Pounded bark is applied on the ulcer Ghana Akpetekplebii 1 Owusu-Sekyere
(2012)
Mitracarpus hirtus (L.) DC
(cited as Mitracarpus villosus
(Sw.) DC.
Leaves Leaves are used to dressed ulcer Ghana Susubiribi 1 Owusu-Sekyere
(2012)
Rutaceae Citrus aurantifolia (Christm.)
Swingle
Fruit,
Root
Decoction used in BU treatment Ghana,
Benin,
Unspeciﬁed 4 Yemoa et al. (2008,
2011), Adjet et al.
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Ivory Coast. A total of 16 plants were individually reported in two
countries consisting of 11 in Benin and Ghana and 5 in Benin and
Ivory Coast. Only 3 plants were reported concomitantly in Benin,
Ivory Coast, and Ghana (Fig. 1).
Cassia alata L., Bauhinia thonningii (cited as Piliostigma thonnin-
gii), Ocimum gratissimum (cited as Ocimum viride), Vernonia amyg-
dalina, Chromolaena odorata, Carica papaya, Periploca nigrescens
(cited as P. nigrescens), Alstonia boonei, Mangifera indica, and
Table 1 (continued )
Family Species Part
used
Formulation and mode of usage Country Common /local
name
Frequency
of citation
References
Ivory
Coast
(2013), Seefeld et al.
(2013), Addo et al.
(2007)
Disinfectants: Root and fruit mixted with
Spathodea campanulata P.Beauv. leaves and
bark are used for ulcer bandage
Leave mixed with Gossypium barbadense L.
leaves
Clausena anisata (Wild.)
Hook. f. ex Benth.
Root Infusion of root used for BU treatment Benin Unspeciﬁed 1 Yemoa et al. (2008,
2011)
Zanthoxylum zanthoxyloides
(Lam.) Zepern. & Timler
Root Decoction of root is used in BU treatment Ghana Unspeciﬁed 1 Addo et al. (2007)
Sapindaceae Paullinia pinnata L. Leaves Decoction/trituration of leaves used for BU
treatment
Benin,
Ghana
Towantin 2 Yemoa et al. (2008,
2011), Seefeld et al.
(2013)
Sapotaceae Vitellaria paradoxa C.F.Gaertn. Leaves Decoction of leaves used for BU treatment. Benin,
Ivory
Coast
N’gouhin
(baoulé)
2 Adjet et al. (2013),
Yemoa et al. (2008,
2011)
Used as pomade or disinfectant
Solanaceae Capsicum annuum L. (cited as
Capsicum frutescens L.)
Fruit Maceration of fruit used for BU treatment Benin,
Ghana
Unspeciﬁed 2 Yemoa et al. (2008,
2011), Addo et al.
(2007)
Nicotiana tabacum L. Leaves The tobacco leaves are pressed in the palms
and the substance obtained are applied to
the wounds for treatment or used as
pomade or disinfectant
Ivory
Coast
Gbosro
(baoulé),
Tobacco leaves
2 Trébissou et al.
(2014)
Adjet et al. (2013)
Solanum erianthum D. Don Leaves Leaf paste used to bandage ulcer Ghana Pepediewuo 1 Sam et al. (2013)
Solanum rugosum Dunal Leaves Leaves are dried under shade for two weeks.
The powder obtained after grinding is
applied to the wound twice a day.
Ivory
Coast
Koumonssi 1 Trébissou et al.
(2014)
Solanum torvum Sw. Leaves Ground leaves are directly applied on the
ulcer
Ghana Abedru 1 Seefeld et al. (2013)
Talinaceae Talinum fruticosum (L.) Juss.
(cited as Talinum triangulare
(Jacq.) Willd.)
Leaves Ground leaves are directly applied on the
ulcer
Ghana Bro-bro 1 Seefeld et al. (2013)
Vitaceae Leea guineensis G. Don Root The pounded root is used for BU treatment Ghana Agyaben 1 Owusu-Sekyere
(2012)
Xanthorrhoeaceae Aloe buettneri A. Berger Leaves Maceration for BU treatment Benin Unspeciﬁed 1 Yemoa et al. (2008,
2011)
Aloe vera (L.) Burm.f. Leaves BU treatment, accelerates wound healing,
burns, sores, ulcers, inﬂammation
Ghana Unspeciﬁed 2 Addo et al. (2007),
Seefeld et al. (2013)
Zingiberaceae Aframomum melegueta K.
Schum.
Fruit Carbonisation fruit is used for BU treatment Benin;
Ghana
Wusa 2 Yemoa et al. (2008,
2011), Seefeld et al.
(2013)
Curcuma longa L. Leaves Leaves decoction is used for BU treatment Benin Unspeciﬁed 1 Yemoa et al. (2008,
2011)
BU¼Buruli ulcer.
Fig. 1. Repartition of plants used to treat Buruli ulcer per country.
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Dysphania ambrosioides (cited as Chenopodium ambrosioides)
(2) Many others were cited only once.
The plant families with more cited species included Apocyna-
ceae and Euphorbiaceae (7), Leguminosae (6), Solanaceae (5),
Phyllanthaceae (4), Anacardiaceae, Annonaceae, Bignoniaceae,
Compositae, Lamiaceae, Meliaceae, Poaceae, and Rutaceae (3),
Araceae, Arecaceae, Capparaceae, Combretaceae, Malvaceae, Mor-
aceae, Musaceae, Rubiaceae, Xanthorrhoeaceae and Zingiberaceae
(2). The other plant families were represented by only one species
as shown in Table 1.
Cultural believes are comparable in West Africa, especially
between Ivory Coast and Ghana who are neighbouring countries,
and Benin. It should also be emphasized that diversity of ﬂoras is
shared by these nations. Plants citation frequency was therefore
expected to corroborate this pattern. The observed disparities
highlight a concern about the reports contents that might indicate
a lack of credibility, or otherwise a rich biodiversity of medicinal
plants with anti-BU potential. This latter option might underline a
poor documentation of plants of interest for BU control, and
therefore indicates that more interest and emphasis should be
developed in this line, especially by local governments and
scientists.
2.1.6. Recipes reports
2.1.6.1. Preparation of ethnopharmacological recipes for BU
control. The ethnopharmacological data including plant parts
used, methods of preparation and administration of potions are
shown in Table 1. The repartition of forms of herbal preparations
and routes of administration and dosage of prescribed herbal
remedies are shown in Figs. 2 and 3, respectively. The
preparation of the medicines employed several methods,
decoction (27%), followed by trituration (20%), infusion (15%),
powders (12%), pomade and maceration (10%). Of note, decoction
and trituration are the fastest approaches when it comes to
potions taken orally or applied to wounds.
Some of these preparations were made from mixtures of
different plant species and used for the treatment of BU: Manihot
esculenta and V. amygdalina; Gossypium hirsutum, Physalis angu-
lata, Delonix regia and Jatropha curcas; C. papaya and Xylopia
aethiopica; Citrus aurantifolia and Spathodea campanulata; Gossy-
pium barbadense, Albizia zygia and Momordica charantia; and
Spigelia anthelmia and Zea mays (Addo et al., 2007; Sam et al.,
2013; Adjet et al., 2013; Seefeld et al., 2013; Trébissou et al., 2014).
Leaves were the most frequently used plant part (53), followed
by root (22), fruit/seed (12), and stem bark/bark (11).
2.1.7. Routes of administration and dosage prescription of herbal
remedies
Bandage or dermal administration (42 citations) was the
predominant route of administration followed by oral administra-
tions (5 citations). The choice for bandage or dermal administra-
tion is consistent given that BU usually starts with painless, raised
skin lesion or papule that may extend from the skin into the
subcutaneous tissue. Therefore, it becomes a serious concern for
rural populations when the oedema breaks down to form an
ulcerated wound that needs bandage and healing. Decoction,
infusion, or maceration were reported as taken orally or used to
wash or disinfect the wound while powders, trituration, and
ointments were applied on the ulcer as bandages (Table 1).
Very few reports described dosage prescriptions and generally
recommendations were to administer the herbal remedies twice
or thrice daily during 3 days to many months or continued until
recovery. The problems associated with dosage used in herbal
remedies prescription have been repeatedly highlighted (Tsabang
et al., 2012; Asase et al., 2010). In fact, the inadequate knowledge
about herbs and their likely contribution to health makes the
herbal dosage concept difﬁcult to understand. It is generally
believed in settings where traditional herbal medicine is keen
that the pharmacological effect of herbs is due to their pretended
active and “safe” components that will only exert quick effect
when taken in large amounts. Almost all the reports made no
mention of possible side effects. But this could be anticipated as
most traditional healers do not, broadly speaking, know of the
probable and signiﬁcance of side effects of their herbal remedies.
Overall, plant potions are mainly used during necrosis ablation
and wound healing phases of treatment (Johnson et al., 2004).
Decoction
27%
Maceration
10%
Powder
12%
Trituration
20%
Pommade
11%
Infusion
15%
Poultice
1%
Unspecified
4%
Fig. 2. Repartition of forms of herbal preparations.
53
22
12
4
11
4 2 1
Fig. 3. Frequency of citation of plant parts used.
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Different plant parts are used under various recipes administered
by oral or topical route. The survey reports identiﬁed many
recipes, the most cited including decoction, maceration, powder,
carbonisation, trituration, pomade, and infusion (Table 1). Many
other plants that are not described in this review have been
reported in BU treatment and against skin ulcers without any
description of recipes. In many occasions, detailed information
about herbal remedies dosage were not speciﬁed, but only the
plant name and route of administration and the outcome were
mentioned.
2.1.8. Potency of herbal remedies in patients with Buruli ulcer and
toxicity
A total of 7 species: Ricinus comminus, Nicotiana tabacum, M.
indica, C. papaya, Solanum rugosum, Cyperus cyperoides (cited as
Mariscus alternifolius), and Moringa oleifera have been administered
to patients and the outcome followed up. The ﬁrst clinical study based
on 6 plants used to treat BU was conducted in three Buruli ulcer
caring and management centers in Ivory Coast. Three preparations
were used, including maceration of R. comminus and N. tabacum,
infusion of M. indica and C. papaya, and powder for S. rugosum and C.
cyperoides that were applied twice or thrice a day on the ulcer. Of a
study population of 273 patients, 219 (80%) were healed (with N.
tabacum, M. indica, S. rugosum and C. papaya), while 41 (15%) had
their ulcer stabilized (with R. comminus and C. cyperoides) and 13 (5%)
felt no effect after treatment. This study highlighted the beneﬁcial
potential of the used herbs remedies (Trébissou et al., 2014). In the
second study, a trial in two groups of 15 children (2–15 years)
attending the Centre St Pio Padio, Ivory Coast and each having clinical
forms of BU showed that after six weeks of treatment, children
receiving normal diet supplemented with 330 mL of aqueous extract
of M. oleifera leaves per meal, had a higher rate of healing compared
to children under normal non supplemented diet (Kodia et al., 2014).
The results achieved by the authors emphasize the added value of
supplementation of the diet with M. oleifera extract. Meanwhile,
understanding the mechanism of efﬁcacy of this medicine could be
helpful in the therapy of BU. Moreover, such beneﬁcial effect should
be validated through more detailed investigations of the added
extract, speciﬁcally its action against the causative mycobacterial
agent or other values such as anti-oedematous, anti-inﬂammatory,
sedative, wound healing, immune inhibition, and inhibition enzymes
involve mycolatone production.
On another hand, close collaboration between herbal practi-
tioners and modern physicians and other health professionals should
be effective to help tackle the impact of the disease in endemic
regions (Johnson et al., 2004; Renzaho et al., 2007). However, no
detailed safety studies were conducted prior to these trials.
To a certain extent, these plants that were reportedly used in
clinical settings to treat BU have undergone safety studies.
Ricinus communis intoxications in humans and animals have
been known for centuries and it is attributed mainly to the toxicity
of ricin, haemagglutinin and ricinine (Worbs et al., 2011). The
seeds are the most toxic part of the plant although the leaves are
also poisonous. The inhalational toxicity (in estimated LD50), for
two different R. communis cultivars in rats has been reported to be
between 3.7 mg/kg and 9.8 mg/kg body weight. In non-human
primates, the LD50 after inhalational application was found to be
5.8 mg/kg for African green monkeys and 15 mg/kg for rhesus
monkeys. The least toxic route is oral uptake or intra-gastric
delivery and is about 1000 times less toxic than parenteral
injection or inhalation. For mice, LD50 values of 21.5 mg/kg and
30 mg/kg were reported (Worbs et al., 2011). In clinical reports,
the number of seeds ingested causing mild to severe symptoms,
including a fatal outcome, range from uptake of only single seed to
up to 30 seeds (Worbs et al., 2011).
Crushed leaves of N. tabacum that are applied on wounds
contain nicotine, malic and citric acids, phenolic acids, ﬂavonoids,
coumarins and enzymes (Lans et al., 2001). An oral LD50 of 50 mg/
kg body weight was observed in rats with no signiﬁcant effects on
hematocrit and bleeding time following 6 weeks of oral adminis-
tration (Ukoha et al., 2012). Meanwhile, The increase in biochem-
ical parameters such as: transaminases and alkaline phosphatase
activities suggested that it may be associated with liver toxicity at
up to 600 mg/kg (Nweze et al., 2015).
The administration of the aqueous decoction from leaves of M.
indica up to a dose of 5000 mg/kg (per os) did not produce any signs
or symptoms of toxicity in treated male Swiss albino mice (Severi
et al., 2009). At this dose range, the extract can be categorized as
safe. It is also documented that the acute toxicity (LD50) of M.
oleifera aqueous extract of 16,100 mg/kg and ethanol extract of
39,800 mg/kg are within the safe range (Kasolo et al., 2012a). The
oral daily administration of LD50 dose of M. oleifera leaves aqueous
extract for 30 days shows features of mild sub-acute toxicity and
indicates safer outcomes (Kasolo et al., 2012b). In another study,
acute toxicity studies of M. oleifera leaves extract in rats showed no
mortality at doses range of up to 2000 mg/kg. However, M. oleifera
is genotoxic at supra-supplementation levels of 3000 mg/kg. In a
sub-acute toxicity study, oral treatments in rats for 21 days with this
extract at 400, 800 and 1600 mg/kg caused varied signiﬁcant
changes in haematological parameters that could be attributable
to the presence of isothiocyanate producing glycosides (Adedapo
et al., 2009). However this results have little scientiﬁc signiﬁcance
given the contradiction with the previously mention ﬁndings. The
subchronic treatment of Sprague Dawley rats for 13 weeks with the
leaf extract of C. papaya showed no signiﬁcant toxicity effect at
doses up to 2000 mg/kg, many orders of magnitude above the
levels employed in traditional medicine (Ismail et al., 2014). Within
the framework of this literature survey, no report on toxicity study
on C. cyperoides and S. rugosum was found.
2.2. Anti-BU plants: In vitro potency, phytochemistry, and toxicity
Many plants with claimed anti-BU potential have undergone
various degrees of scientiﬁc investigations as evidenced in this
review. Brieﬂy, reported scientiﬁc investigations include botanical
identiﬁcation and plant collection, aqueous/organic extraction and
in vitro testing against M. ulcerans, the causative agent of BU.
Generally, active extracts are further fractionated on a bio-guided
basis using chromatographic techniques to isolate the bioactive
natural products. In the following subsections, data reported on
in vitro potency against M. ulcerans of 13 species (including a
mixture of two species; tonic 1) used in traditional treatment of
BU are presented (Table 2). In addition, reported phytochemical
and toxicological data on plants as well as isolated active com-
pounds are presented.
2.2.1. Aglaonema commutatum Schott.
A. commutatum is an erect herbaceous common ornamental plant
that is used to treat BU. Extract from this plant showed anti-M.
ulcerans activity with MIC value of 40 mg/mL (Table 1) (Addo et al.,
2007). Leaves juice was reported to be used to heal wounds. It was
also shown to exhibit inhibitory effects on Escherichia coli, Pseudomo-
nas aeruginosa and Staphylococcus aureus commonly involved in
burns and wound infections that can account for its anti-BU potential.
Very few studies have been reported on this plant. The main report
referred to its poisonous crystals and its use as ornamental plant. All
parts of the plant contain calcium oxalate crystals that can cause
inﬂammation and irritation of the gastrointestinal tract with some
fatalities reported (Fuller and McClintock, 1986).
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2.2.2. Aloe vera (L.) Burm. f.
A. vera is a perennial plant widely used for the treatment of
various ailments including BU (Addo et al., 2007; Seefeld et al.,
2013). Leaf extract showed MIC value of 40 mg/mL (Table 2) (Addo
et al., 2007) on M. ulcerans. Numbers of its chemicals have been
identiﬁed such as carbohydrate polymers; glucomannans, pheno-
lic compounds such as chromone and anthraquinone. Naturally
the gel is used for its wound healing potential as its high content
in water can keep the wound moist and promote epithelial cell
migration. In addition, the main carbohydrate, mannose 6-phos-
phate, has been suggested to play a signiﬁcant role in the wound
healing potential of A. vera gel (Davis et al., 1994; Bruneton, 1995).
In fact, the binding of mannose 6-phosphate to the growth factor
receptors on the surface of the ﬁbroblasts increases both collagen
and proteoglycan synthesis that directly stimulates macrophages
and ﬁbroblasts resulting in tissue reparation. Similarly, acemannan
puriﬁed from leaves, has showed to accelerate wound healing and
reduce radiation induced skin reactions through macrophage
activation and consequently may stimulate the release of ﬁbro-
genic cytokines otherwise growth factors may directly bind to
acemannan and promote their stability and extend the stimulation
of granulation tissue. Genin, a saponin contained in A. vera, has
also been reported as involved in wound healing activity
(Mukherjee et al., 2014; Davis et al., 1994; Bruneton, 1995). Studies
of the growth of normal human cells in vitro demonstrated that
cell growth and attachment were promoted by exposure to fresh A.
vera leaves, whereas a stable gel preparation was shown to be
cytotoxic to both normal and cancer cells. However, the cytotoxic
effects of the gel were thought to be due to the addition of other
substances to the gel during processing (Winters et al., 1981).
Treatment over 6 months with A. vera in rats did not induce
tolerance in the sense of a reduced laxative effect. Meanwhile,
prolonged use or overdosage may cause nephritis, vomiting,
bloody, mucus, or watery diarrhoea leading to electrolyte imbal-
ance and hemorrhagic gastritis. A. vera gel has been reported to
cause contact and photo dermatitis or erythema with papulous
when administered on the skin, despite its anti-inﬂammatory
potential and ability to heal wounds. In ten control trials involving
803 subjects no withdrawals or signiﬁcant side reactions was
observed, and the benign adverse reactions mainly involved
burning after topical application, contact dermatitis and mild
itching. All adverse effects were reversible and A. vera was
generally well tolerated (Mukherjee et al., 2014).
2.2.3. Alstonia boonei De Wild.
Alstonia is a widespread genus of evergreen trees and shrubs.
The leaves paste of A. boonei is used for daily bandage of washed
ulcer in BU treatment. Addo et al. (2007) reported it to have
activity in vitro against M. ulcerans with MIC value of 40 mg/mL
(Table 1). This plant known for its wound healing properties
contains complex polysaccharides in abundance, mainly mucilages
but also alkaloids, tannins, steroids, saponins, glycosides, ﬂavo-
noids, triterpenoids, and terpenoids (Chime et al., 2013;
Igbinaduwa and Obasuyi, 2012). This diversity of bioactive sec-
ondary metabolites found in this plant might sustain its effect
against BU. The acute toxicity dose of the ethanolic and methanolic
extracts (root & bark) of A. boonei was shown to be above
5000 mg/kg body weight (Iyiola et al., 2011; Onwusonye et al.,
2014). Histological examination of liver sections of mice also
showed relatively normal histological features (Onwusonye et al.,
2014). The stem bark hydroethanolic extract showed no effect in
guinea-pigs kidney at 50 and 200 mg/kg following 2 weeks of
treatment. On another hand, extract dose of 200 mg/kg signiﬁ-
cantly raised blood urea, creatinine, potassium, and chloride ions
levels by the 4th week and the kidney cells showed obvious
histological signs of potential toxicity (Oze et al., 2006), indicating
that A. boonei potions should be taken with caution.
2.2.4. Capsicum annum L.
C. annum is a perennial shrub, with woody trunk which bears
green fruits that ripen to red. The fruits are widely known in
tropical Africa where they are largely used as spices for pepperish
taste. The maceration of fruit is used for BU treatment and has
showed MIC value of 40 mg/mL on 7 M. ulcerans isolates (Table 2)
(Addo et al., 2007). A phytochemical study of C. annum established
the presence of reducing compounds, saponins, alkaloid salts,
alkaloids, quarternary bases, anthracenosides, ﬂavanosides,
Table 2
Bioactive plants used in the traditional treatment of Buruli ulcer.
Species Extract origin In vitro activity (MIC in lg/
mL)
References
Aglaonema commutatum Schott Leaves boiled in water for 5 min 40 (cited as 1:5 (20%w/v)) Addo et al. (2007)
Aloe vera (L.) Burm.f. Leaves macerated in water 40 (cited as 1:5 (20%w/v)) Addo et al. (2007)
Alstonia boonei De Wild. Leaves macerated in water 40 (cited as 1:5 (20%w/v)) Addo et al. (2007)
Capsicum annuum L. (cited as Capsicum frutescens L.) Fruit macerated in water 40 (cited as 1:5 (20%w/v)) Yemoa et al. (2008, 2011); Addo
et al. (2007)
Gratiola ofﬁcinalis L. Bark boiled in water for 20 min 1.56–25 (cited as 0.78–
12.5%(V/V))
Addo et al. (2007)
Holarrhena ﬂoribunda (G.Don) T. Durand et Schinz Roots macerated in 70% ethanol 125 Yemoa et al. (2011)
Jatropha curcas L. Leaves macerated in 70% ethanol 250 Yemoa et al. (2011)
Sacoglottis gabonensis (Baill.) Urb. Stem bark macerated in water 780 Kone et al. (2007)
Spathodea campanulata P.Beauv. Leaves macerated in water 40 (cited as 1:5 (20%w/v)) Addo et al. (2007)
Spigelia anthelmia L. Leaves and grains boiled in water
for 5 min
6.25–25 (cited as 3.13–12.5%
(V/V))
Addo et al. (2007)
Syzygium aromaticum (L.) Merr. & L.M.Perry (cited as Eugenia
aromatica (L.) Baill.)
Seed boiled in water for 20 min 25 (cited as 12.50% (V/V)) Addo et al. (2007)
Tonic 1: Zea mays L.þSpigelia anthelmia L. Grains and leaves boiled for 5 min
in water
6.25–25 (cited as 3.13–12.5%
(V/V))
Addo et al. (2007)
Zanthoxylum zanthoxyloides (Lam.) Zepern. & Timler Roots boiled in water for 20 min 12.5–25 (cited as 6.25–
12.5% (V/V))
Addo et al. (2007)
w/v¼20% w/v (200 mg/mL) of herbal preparations (infusions, decoctions and juices) were each incorporated at 1:5 dilution into L–J medium corresponding to a ﬁnal
concentration of 40 mg/mL. V/V¼; The herbal preparations that exhibited anti-M. ulcerans activity were incorporated into L–J media at two-fold serial dilutions (1st to 8th
dilution). For MICs, consequently, the infusions, decoctions and juices at 20% w/v were incorporated into L–J media at ﬁnal concentrations ranging from 25% vol/vol to 0.20%
vol/vol corresponding to 50 mg/mL to 0.4 mg/mL (Addo et al., 2007).
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ﬂavonoids, coumarin derivatives, steroid glycosides and anthocya-
nosides (Lagu and Kayanja, 2013). C. annum also contains a
complex mixture of essential oils, waxes, coloured materials
(mainly capsanthin, capsorubin, zeaxanthin, cryptoxanthin, and
lutein), and several capsaicinoids (Wesołowska et al., 2011). Study
by Lagu and Kayanja (2013) indicated a LD50 of 12,043 mg/kg for
aqueous extracts of C. annum and 5492 mg/kg for 70% ethanolic
extracts and concluded that the aqueous and 70% ethanolic
extracts are safe to use and are classiﬁed as basically non-toxic
(5000–15,000 mg/kg body weight). Indeed the complex chemical
composition of C. annum fruit appears to be an advantage in
exerting beneﬁcial biological activities. However, other studies
have demonstrated that a capsaicinoid derivative, capsaicin has
oral LD50 values as low as 161.2 mg/kg in rats and 118.8 mg/kg in
mice. In addition, haemorrhage of the gastric fundus was observed
in some of the animals that died. Intravenous, intraperitoneal, and
subcutaneous LD50 values were lower. In subchronic oral toxicity
studies using mice, capsaicin produced statistically signiﬁcant
differences in the growth rate as the liver/body weight increased
(Cosmetic Ingredient Review Expert Panel, 2007). Capsaicin is an
active component of chili peppers, which are plants belonging to
the genus Capsicum. It is an irritant for mammals, including
humans, and produces a sensation of burning in any tissue with
which it comes into contact. Capsaicin is used as an analgesic in
topical ointments, nasal sprays, and dermal patches to relieve pain.
These beneﬁcial features of capsaicin if well managed, could add
value to the use of medicinal plants to control BU.
2.2.5. Jatropha curcas L.
J. curcas is a tree that is reportedly used in traditional medicine
to cure BU. Its leaf ethanolic extract inhibited the growth of M.
ulcerans with MIC value of 250 mg/mL. Numerous biologically
active compounds have been isolated and characterized from all
parts of this plant including ﬂavanoids, apigenin, vitexin, isovi-
texin, sterol, stigmasterol, β-D-sitosterol, β-D-glucoside, sapogen-
ins, alkaloids, triterpenae alcohol and 1-triacontanol (Prasad et al.,
2012). The latex contains proteolytic enzymes that have been
suggested to provide signiﬁcant wound healing activity (Lans
et al., 2001). Although fatalities with Jatropha poisoning are rare,
Abdu-Aguye et al. (1986) demonstrated that oral seeds adminis-
tered to mice can cause macroscopic anal haemorrhage and death.
They also found that extract of the seed administered intraper-
itoneally in mice can cause death in doses as low as 1 mg/kg
(Abdu-Aguye et al., 1986). Singhal et al. (2013) studied the clinical
and biochemical proﬁles of eight children with J. curcas poisoning
and observed lethargy, severe abdominal pain, inability to ingest,
and intense thirst amongst the most prominent complaints in all
children (Singhal et al., 2013).
2.2.6. Holarrhena ﬂoribunda (G.Don) T. Durand
H. ﬂoribunda grows as a shrub or tree (Yemoa et al., 2008) and
is used to treat BU. Yemoa et al. (2011) reported that H. ﬂoribunda
root ethanol extract inhibited the growth of M. ulcerans with MIC
value of 125 mg/mL. The methylene chloride fraction of this extract
containing alkaloids also inhibited the growth of M. ulcerans with
an MIC value of 125 mg/mL as well as the alkaloid-rich extract
(MIC¼62.5 mg/mL). Chemical compounds isolated from H. ﬂori-
bunda include holaphylline, holaphyllamine, holamine, holaphylli-
nol, holaphyllidine, holadysamine, holarrhesine, conessine, and
progesterone (Yemoa et al., 2015). Holamine, holaphyllamine and
holaphylline showed signiﬁcant anti-inﬂammatory properties that
can add value to the anti-BU properties. They cause sodium
retention and act as diuretics in rats. Aqueous extracts of root
bark, stem bark and leaves showed relatively low toxicity
(Schmelzer, 2006). Overall, the bioactive components isolated
from this plant support its use in traditional medicine to treat BU.
2.2.7. Sacoglottis gabonensis (Baill.) Urb.
S. gabonensis is a tropical rain forest tree used in traditional
medicine to treat BU. The stem bark decoction is taken orally or used
for disinfection of ulcer or covered with ﬁne powder as bandage. Its
aqueous extract showed promising activity against M. ulcerans
in vitro (MIC¼780 mg/mL) (Kone et al., 2007) (Table 2). The phyto-
chemical screening of its stem bark extract showed the presence of
sterols, polyterpenes, polyphenols, ﬂavonoids, tannins, saponins and
alkaloids. Sofowora (1996) also reported that these compounds are
responsible for the biological activities of a plant. The acute and
subacute toxicity studies of the aqueous extract of this plant showed
a LD50 value of 5000 mg/kg in mice per os whereas a 28 day
administration of up to 350 mg/kg/day did not signiﬁcantly inﬂu-
ence haematological and biochemical parameters (Kone et al., 2009).
2.2.8. Solanum torvum Sw.
S. torvum is a commonly used herb in traditional medicine that
possesses antiulcer activity (Agrawal et al., 2010). The antimicro-
bial properties of its leaves have been reported in Gabon for cuts
and wounds (Schippers, 2004). Its leaf decoction that is used to
treat BU has been reported to act against M. ulcerans with MIC
value of 40 mg/mL (Table 1) (Addo et al., 2007). S. torvum revealed
the presence of ﬂavanoids, alkaloids, sterols and triterpenes which
may be responsible for anti-ulcer property (Agrawal et al., 2010).
This plant also contains number of steroidal glycosides among
which torvoside A–H are considered to be furostanol glycosides.
Torvoside M and N have antimicrobial activity and cytotoxic effect
on PC-12 and HCT-116 cell lines. Non alkaloidal constituents like
tetratriacontanoic acid, sitosterol, stigmasterol and campesterol
have also been isolated and identiﬁed from S. torvum leaves
(Agrawal et al., 2010). Acute intoxication with poisonous S. torvum
berries appears to cause toxic myopathy. The constituents directly
responsible for this effect remain unknown; however, there is a
higher likelihood of the class of solanaceous steroidal glycoalk-
aloids. Indeed, steroid glycoalkaloids inhibit serum and erythro-
cyte acetylcholinesterase and butyrylcholinesterase and lead to
clinical manifestations including gastrointestinal distress, cranial
nerve abnormalities, and respiratory weakness. Electrophysiologi-
cal ﬁndings have never been described in affected patients (Glover
et al., 2014). Solasonine, larger amounts of solamargine, and other
steroidal glycoalkaloids have been isolated in the toxic berry
strains. S. torvum poisoning can produce signiﬁcant neurological
and gastrointestinal effects which appear to be mediated by
steroidal glycoalkaloids present in the berries (Smith et al.,
2008). Given this toxicity scale, use of this plant part in patients
should therefore be avoided.
2.2.9. Spathodea campanulata P. Beauv.
The used of S. campanulata has been reported in the treatment
of BU and relief for skin conditions, swollen cheeks, and body
rashes. The leaves and stem bark paste are used to bandage ulcers
while infusions of the leaves, root and bark are also used to clean
ulcers (Adjet et al., 2013; Sam et al., 2013; Addo et al., 2007; Yemoa
et al., 2008). Root decoction showed inhibitory potency on 7 M.
ulcerans isolates with MIC value of 25 mg/mL (Table 1) (Addo et al.,
2007). Preliminary phytochemical screening revealed the presence
of carbohydrates, alkaloids, tannins, and glycosides in extracts of
ﬂowers, and of steroids, carbohydrates, proteins, tannins glyco-
sides and alkaloids in the bark of the plant (Ilodigwe et al., 2010a).
Tannins, saponins, anthraquinone glycosides, and ﬂavonoids were
also identiﬁed in leaves (Ilodigwe et al., 2010b). The acute toxicity
potential in mice showed an estimated LD50 of 4500 mg/kg with
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the ethanolic leaf extract (Ilodigwe et al., 2010a) with no mortality
during the period of study but the animals showed signs of
anorexia, weakness, sluggishness and signiﬁcant (po0.05) reduc-
tion in food and water intake and body weight. In the subchronic
study, 750–3000 mg/kg of the extract were administered daily for
90 days and showed non-signiﬁcant effect on haematological
parameters while liver biochemical markers transaminases and
alkaline phosphatase were increased followed by recovery 28 days
post-treatment (Ilodigwe et al., 2010b).
2.2.10. Syzygium aromaticum (L.) Merr. & L.M. Perry
S. aromaticum is a tree commonly known as clove tree. It is
widely used as analgesic and antiseptic primarily in dentistry for
its main ingredient eugenol. Reports indicate that it is traditionally
used externally or locally for the treatment of minor infections of
the mouth and skin, dressing of minor wounds, and BU (Dalziel,
1956; Addo et al., 2007). In vitro screening of its seeds against M.
ulcerans showed MIC value of 25 mg/mL (Table 1) (Addo et al.,
2007). Besides, various studies have been carried out on the
chemistry of S. aromaticum revealing that clove buds contain 15–
20% essential oil, with high content in eugenol (70–85%), eugenyl
acetate (15%) and β-caryophyllene (5–12%). Other reported com-
pounds in clove buds include vanillin, crategolic acid, tannins,
gallotannic acid, methyl salicylate, ﬂavonoids, eugenin, kaemp-
ferol, rhamnetin, eugenitin and triterpenoids like oleanolic acid
(Mittal et al., 2014). The European Medicines Agency, (2011)
reported that acute toxicity of a decoction of clove studied in 30
mice fasted overnight showed no respiratory, gatrointestinal tract,
central nervous system symptoms, behavioural patterns and
mortality and exhibited LD50 of 263 mg/kg (i.p.) and 2500 mg/kg
(oral). No signs of mortality or gross behavioural changes were
observed either after administration of 500 mg/kg of ethanolic
extract (DER app. 10:1, ethanol 50%) p.o. Also, a single oral dose of
140 mg/animal killed rats within a short period of time. Other
studies also indicated that undiluted clove oil applied on the
dorsal skin of hairless mice did not cause irritation. On intact or
shaved rabbit skin clove essential oil acted under occlusive
conditions as a weak irritant. Phototoxic effects were not observed
with undiluted clove oil on hairless mice and pigs. Signiﬁcant
alterations in liver enzymes and haematological parameters were
reported after 90 days of administration of a decoction of clove at
doses of 300 mg/kg and 700 mg/kg in rats. Even at lower dose,
histopathological modiﬁcations could be found in body organs.
The authors concluded that a prolonged use of decoctions of clove
should be avoided. Clove essential oil in oral dosages of 35 or
70 mg per animal (rat) over 8 weeks was tolerated without signs
of toxicity. Higher doses led to inactivity and weight loss. About
105 mg/animal p.o. daily for 2 to 3 weeks led to serious liver and
kidney damage and death of the animals (European Medicines
Agency, 2011). On another hand, all animals died within 24 h after
oral administration of 5000 mg/kg of the essential oil in rats and
the autopsy showed bleeding in the stomach and intestines, and
pleural effusion (European Medicines Agency, 2011). Essential oils
are complex lipophilic mixtures that are highly diffusible across
cell membranes and might exert signiﬁcant toxicity effect on
organs when taken orally or injected at high undiluted doses.
Caution should therefore be paid while using these substances
that are otherwise beneﬁcial when used with moderation.
2.2.11. Tonic 1: Mixture of Spigelia anthelmia L. and Zea mays L.
The mixture of Z. mays grain and S. anthelmia leaves reported as
used in traditional BU treatment showed growth inhibition of 7 M.
ulcerans isolates with MIC values of 6.25–25 mg/mL (Table 1) (Addo
et al., 2007).
– Spigelia anthelmia L.
S. anthelmia is a common annual weed of cultivation in open
re-growths, on unused land in towns (Jegede et al., 2006).
Phytochemical investigation has described the isolation of the
alkaloid spiganthine, volatile alkaloids, isoquinoline and acti-
dine isomer, and three quaternary alkaloids, choline, benz-
oylcholine and 2,3-dimethylacrolyl choline, phenolcarboxylic
acids and ﬂavonoids (Maia de Morais et al., 2002). The acute
toxicity study by intraperitoneal administration of the aqueous
extract of S. anthelmia showed a LD50 value of 1140 mg/kg in
rats (Jegede et al., 2006). The ethyl acetate extract also showed
LD50 values of 345.9 mg/kg and 60.8 mg/kg, respectively
through oral and intraperitoneal administration in Swiss albino
mice (Camurça-Vasconcelos et al., 2004).
– Zea mays L.
Z. mays corn silk is rich in phenolic compounds, particularly
ﬂavonoids. It also contains proteins, vitamins, carbohydrates,
calcium, potassium, magnesium and sodium salts, volatile oils
and steroids such as sitosterol and stigmasterol, alkaloids, and
saponins (Hasanudin et al., 2012). A 90 days toxicity study
using male and female Wistar rats conﬁrmed that Z. mays corn
silk is non-toxic in nature with no histopathological and
adverse effects observed at 9354 and 10,308 mg/day/kg body
wt. respectively (Hasanudin et al., 2012).
2.2.12. Zanthoxylum zanthoxyloides (Lam.) Zepern. & Timler
Z. zanthoxyloides is an indigenous plant widespread in West
Africa that is used to treat BU. Report indicates that it showed
inhibitory activity against M. ulcerans (MIC values 12.5–25-mg/mL
(Table 1) (Addo et al., 2007). Z. zanthoxyloides contains essential
oils, alkaloids, coumarins, sterols as well as several aliphatic and
aromatic amides (Matu, 2011). Methanolic extract of Z. zanthox-
yloides root-bark (cited Fagara zanthoxyloides) showed LD50 at
5000 mg/kg body weight with signs of cerebral irritation before
death and also congestion and focal necrosis of the liver and renal
tubules after histopathological examinations of the viscera.
Authors however declared the safety of the extract, even if the
cerebral mechanism that led to death of the mice needed to be
investigated (Ogwal-Okeng et al., 2003).
2.3. Compounds with potency on Mycobacterium ulcerans
Currently, there is only one study that attempted to use isolated
active ingredients from plants to treat BU, highlighting the poor
emphasis given to research into new chemotherapeutic agents
against BU. The authors reported the isolation of four compounds
including Holadysamine and three others compound A, B, and C
for which chemical structures are yet to be conﬁrmed according to
the authors (Yemoa et al., 2015). Yet the authors tentatively
suggested the compounds structures based on LC–MS data on
compounds A, B, C combine to bibliographic data on compounds
isolated from H. ﬂoribunda. They could correspond respectively to
holaphyllinol (MW: 331.29), holamine, or holaphyllamine (MW:
315.26), N,N-diméthyl holamine or méthyl holaphylline (MW:
343.29). Further analysis of spectroscopic data on C showed the
presence of a fragment at m/z 326 ([MH2OþH]þ) and the loss of
a water molecule in its MS/MS fragmentations allowed them to
propose an alcoholic and not a ketonic function on C20 (Fig. 4).
Meanwhile Holadysamine showed MIC value of 50 mg/mL against
the causative agent of BU, while compounds A, B and C were less
active (125 mg/mL).
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3. Conclusion and future perspectives
Among the 98 species reportedly used to treat BU, 7 species
were validated through trials in BU patients. In addition, 13 were
subjected to further studies supported by pharmacological inves-
tigations. Globally, it appears that ethnopharmacological data for
this topic is scarce. Also, the reported results of pharmacological
investigations highlighted some degree of inconsistency among
ﬁndings, but also showed promise and indicated that more
emphasis should be given to well-planned and coordinated
validation studies on all the plants with claimed anti-BU potential.
Furthermore, careful attention should be paid while diagnosing BU
because it may be confounded with other causes of ulcers
especially in rural communities. The gap in knowledge remains
huge. Therefore further studies should clearly demonstrate the
in vitro and in vivo activities of crude extracts and further
characterized fractions, as well as safety in humans.
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